Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Trending Now
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
Breaking News
Surgical innovation in dry eye disease: Salivary gland transplant
Ağustos 27, 2025
Next-generation IOLs advance complex cataract care
Ağustos 26, 2025
OCT changes with low-level red light therapy for myopia in children
Ağustos 26, 2025
Alcon presenting at APACRS 2025
Ağustos 21, 2025
Breaking News
Popular Now
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
The 2nd International Glaucoma Symposium underscores how AI and advanced imaging are…
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
(Image Credit: AdobeStock/littlewolf1989) A press release from Mass General Brigham, Boston, reported…
Collaborate With Us
Join forces with Ophthalmology News to reach a global community of eye care professionals. Whether you want to contribute an article, share research, or explore partnership opportunities, we’d love to hear from you.
Editor Choice
Updates On Central Serous Chorioretinopathy
Central serous chorioretinopathy, commonly referred to as CSC, is a condition in…
Alcon Signs $770 Million Deal to Acquire Aerie Pharma. I OBN
Swiss eye care company Alcon AG announced on Tuesday that it has…
Selagine and Grifols Team Up for DED Eye Drops
Selagine announced a global collaboration with Grifols to develop and commercialize immunoglobulin…
Apotex Recalls Brimonidine Tartrate Ophthalmic Solution
Apotex Corp. has initiated a voluntary recall at the consumer level for…
Akorn Pharmaceuticals Files for Bankruptcy
Akorn Pharmaceuticals, a maker of generic and branded drugs, has announced that…
3D-printed Smart Contact Lens with Navigation Function
Dr. Seol Seung-Kwon’s research team on Smart 3D Printing at KERI, in…
M1 Molecule: A Promising Treatment for Optic Nerve Injury
Traumatic injury to the central nervous system (CNS), spinal cord, and optic…
HealthCare Royalty And Clearside Bio to Enter Into Agreement
Clearside Biomedical announced it has entered into an agreement with HealthCare Royalty…
Noninferiority randomised trials in ophthalmology – Eye – Nature
Noninferiority randomised trials in ophthalmology – Eye Nature Source: Author: | Date: 2023-03-03…
Worth Reading
Meeting expectations with evolving technology
Ağustos 26, 2025
/ Patient Education, Research & Studies, Technology & Innovation, Treatments & Surgery
Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Ağustos 26, 2025
/ Industry News, Patient Education, Research & Studies, Treatments & Surgery
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
Ağustos 26, 2025
/ Patient Education, Research & Studies
Next-generation IOLs advance complex cataract care
Ağustos 26, 2025
/ Patient Education, Research & Studies, Treatments & Surgery
Subscribe Now
Enter your email address below and subscribe to our newsletter